By Fiona Chin N.D. 
Emerging therapies are changing the future of chronic disease treatment. Stem cells, exosomes, peptides, gene therapy and regenerative medicine are creating exciting new possibilities for conditions once considered untreatable.
In this episode of The Kidney Coach Podcast, Fiona Chin is joined by integrative longevity physician Dr. Alexander Grinberg to explore the latest advances in regenerative medicine. Together, they discuss how these emerging therapies may transform the treatment of chronic kidney disease (CKD), autoimmune disease, ALS, multiple sclerosis (MS), fibrosis, diabetes, neurodegenerative diseases and healthy ageing.
First, Dr. Grinberg explains the differences between mesenchymal stem cells, MUSE cells and small mobile stem cells (SMS cells). He then explores the growing role of NK cell exosomes, peptide therapy, senolytics and gene therapy in regenerative medicine.
Next, the conversation focuses on treatment sequencing. Rather than relying on a one-size-fits-all approach, many clinicians now combine therapies to achieve better outcomes. For example, peptides may help prepare or “prime” the body before advanced regenerative treatments. As a result, patients may respond more effectively to stem cells, exosomes or other biological therapies.
The discussion also examines the future of personalised medicine. Genetics, epigenetics and artificial intelligence are helping practitioners create highly individualised treatment plans. In addition, the episode explores cell banking, induced pluripotent stem cells (iPSCs) and personalised cellular reprogramming.
Finally, Fiona and Dr. Grinberg discuss why regenerative medicine is creating new hope for people living with chronic illness. They also examine promising research into fibrosis reversal, autoimmune disease, kidney disease, longevity medicine and next-generation therapies that may change the future of healthcare.
Topics Covered:
00:00 – Introduction
02:32 – The Future of Regenerative Medicine
03:22 – Stem Cells, Exosomes & Gene Therapy
05:59 – Can Chronic Disease Be Reversed?
07:14 – Combining Peptides, Cells & Gene Therapies
08:47 – Senolytics & Cellular Rejuvenation
09:48 – Why Sequencing Therapies Matters
11:21 – Different Types of Stem Cells Explained
12:03 – Small Mobile Stem Cells (SMS Cells)
15:03 – SMS Cell Trials & Fibrosis Research
16:34 – MUSE Cells & Immune Modulation
19:28 – Stem Cells for Kidney Disease & Transplants
22:17 – SMS Cells for Stroke & Neurological Recovery
24:03 – Early Stem Cells & Metabolic Health
27:22 – Exosomes vs Secretomes Explained
28:58 – NK Cells & Immune Therapies
30:49 – NK Exosomes for Cancer & Viruses
32:20 – Autoimmunity, Viruses & Molecular Mimicry
35:02 – Peptides & Regenerative Medicine
36:08 – Antimicrobial Peptides & Chronic Infections
38:45 – FOXO3, Klotho & Longevity Peptides
40:27 – Dr. Grinberg’s Personal Longevity Protocol
42:26 – Why Personalized Protocols Matter
44:18 – Kidney Disease, Fibrosis & Regeneration
46:04 – Accessing Emerging Therapies
48:15 – AI, Precision Medicine & Patient-Led Innovation
50:42 – Cell Banking & Cellular Reprogramming
54:02 – ALS, Stem Cells & Future Clinical Trials
56:52 – Reprogramming Immune Cells in Autoimmunity
58:12 – Hope for MS, CKD & Chronic Disease
59:11 – Type 1 Diabetes & Regenerative Therapies
1:03:09 – Alpha-Klotho Gene Therapy
1:05:11 – The Future of Longevity Medicine
1:07:07 – Why Hope & Innovation Matter
